The Anti-Doping Database contains verified anti-doping rule violations registered for Lithuania. This country profile provides aggregated statistics across sports, substances, testing types and sanction lengths, including trends over time and active sanctions.
In Lithuania, the sport with the highest number of anti-doping rule violations is Track and field, while the most frequently detected substance is Erythropoietin. The average suspension length for sanctioned athletes is 24 months.
In Lithuania, 25% of the anti-doping rule violations in the database come from out-of-competition testing, while 75% are from in-competition tests.
The data below is generated dynamically from disciplinary decisions, published testing programs and official anti-doping authority reports. No individual athlete information is displayed on this page; the focus is entirely on high-level patterns and long-term trends.
The ranking above shows how Lithuania compares to other countries in the Anti-Doping Database based on registered anti-doping rule violations.
Erythropoietin (EPO) is a naturally occurring hormone that stimulates red blood cell production. Synthetic EPO became available as a pharmaceutical drug in the late 1980s, primarily for medical use in patients with anemia and kidney disease. Related drugs, such as Darbepoetin Alfa, have since been developed.
In sports, EPO enhances oxygen-carrying capacity by increasing red blood cell count, providing significant advantages in endurance events such as cycling, long-distance running, and cross-country skiing. The increased oxygen delivery to muscles can dramatically improve stamina and performance.
Artificially elevated red blood cell levels thicken the blood, significantly increasing the risk of serious cardiovascular complications including blood clots, heart attack, stroke, hypertension, seizures, and congestive heart failure. The risks are particularly acute during sleep when heart rate naturally decreases, as the thickened blood becomes more difficult to circulate at lower heart rates.
EPO was added to the IOC prohibited list in 1989, initially categorized under peptide hormones and analogues. However, testing methods were not immediately available, allowing widespread use in the early 1990s.
On August 1, 2000, the IOC Medical Commission approved two detection methods for EPO based on isoelectric focusing and double immunoblotting, which distinguish between natural and synthetic EPO in urine samples. Modern detection methods and hematocrit monitoring have made EPO use more detectable, though related substances and microdosing practices continue to challenge anti-doping authorities.
Belgian cycling champion Eddy Planckaert later confessed to experimenting with EPO in 1991, his final professional year, stating that many riders were using the substance during that period. Several Dutch and Belgian cyclists died suddenly in the late 1980s and early 1990s, sparking widespread concern about EPO's dangers.
However, academic research has questioned whether EPO was the cause of these deaths. A 2011 study by sports historian Bernat López examined claims that 18 Dutch and Belgian cyclists died from EPO use between 1987-1990 and found the claim lacked empirical evidence. López noted that reported numbers varied wildly across sources (from 6 to 40 deaths) and that most sudden deaths in young athletes are attributed to underlying cardiac conditions rather than drug use. The study concluded that the "18 deaths" narrative functioned more as anti-doping propaganda than historical fact.
The balance between In-Competition and Out-of-Competition testing reveals the maturity of a country's anti-doping program.
A higher proportion of OOC tests typically indicates a more proactive approach to deterring doping during training periods.
This profile shows aggregated anti-doping rule violation data for Lithuania, including trends over time, most affected sports, substance patterns and active sanctions. Detailed case information is available to registered users inside the Anti-Doping Database.
Used by journalists, sport lawyers, NADOs and researchers worldwide for proactive strategy — not just post-case research.
As a subscriber you get instant access to verified, structured anti-doping case data — from hours of research to seconds:
The Anti-Doping Database currently contains 14,914 verified anti-doping rule violations across all sports and all countries, and is updated regularly.